According to an exchange filing, pharma firm Zydus has appointed Akhil Monappa and Upasana Kamineni Konidela as independent directors, after approval during the Extraordinary General Meeting.
Both of them are not related to any other director and aren't debarred from becoming independent directors by SEBI.
(To receive our E-paper on WhatsApp daily, please click here. To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)
